BIOMAT Database Logo BIOMAT Database Logo

[Glurenorm a new peroral antidiabetic agent belonging to the group of sulfonylurea compounds]. 1976

M Grujić, and B Rizvanbegović, and M Perinović, and I D Perinović

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013453 Sulfonylurea Compounds A class of compounds in which a sulfone functional group is attached to UREA. Compounds, Sulfonylurea

Related Publications

M Grujić, and B Rizvanbegović, and M Perinović, and I D Perinović
[Glybenclamide (HB 419): a new oral antidiabetic agent of the sulfonylurea group].
April 1969, Deutsche medizinische Wochenschrift (1946),
M Grujić, and B Rizvanbegović, and M Perinović, and I D Perinović
[Glibornuride (Glutril). A new peroral antidiabetic agent].
March 1974, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
M Grujić, and B Rizvanbegović, and M Perinović, and I D Perinović
[Peroral antidiabetics: sulfonylurea compounds].
July 1985, Ugeskrift for laeger,
M Grujić, and B Rizvanbegović, and M Perinović, and I D Perinović
[A new antidiabetic sulfonylurea].
January 1960, Therapeutische Umschau. Revue therapeutique,
M Grujić, and B Rizvanbegović, and M Perinović, and I D Perinović
[Experiences with the oral antidiabetic agent, Glurenorm, in diabetics with kidney diseases].
September 1975, Medizinische Monatsschrift,
M Grujić, and B Rizvanbegović, and M Perinović, and I D Perinović
[Clinical pharmacology of ofloxacin: a new chemotherapeutic agent belonging to the gyrase inhibitor group].
January 1986, Infection,
M Grujić, and B Rizvanbegović, and M Perinović, and I D Perinović
[Clinical study of a new sulfonylurea antidiabetic, glibornuride].
December 1972, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
M Grujić, and B Rizvanbegović, and M Perinović, and I D Perinović
CLINICAL STUDY OF TOLAZAMIDE: A NEW ANTIDIABETIC SULFONYLUREA.
June 1965, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society,
M Grujić, and B Rizvanbegović, and M Perinović, and I D Perinović
A new antidiabetic agent.
December 1974, Journal of the Indian Medical Association,
M Grujić, and B Rizvanbegović, and M Perinović, and I D Perinović
[Chemistry and pharmacology of a new peroral antidiabetic: ambolin].
April 1957, Praxis,
Copied contents to your clipboard!